The KCNQ1 Gene Long QT Syndrome Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the KCNQ1 gene, which are associated with Long QT Syndrome Type 1 (LQTS1). LQTS1 is a rare inherited heart condition that can lead to irregular heartbeats, fainting, and sudden death due to its influence on the heart's electrical activity. The test involves analyzing the patient's DNA to detect any genetic abnormalities in the KCNQ1 gene, which plays a crucial role in the proper function of heart cells.
By identifying specific mutations in the KCNQ1 gene, healthcare providers can better understand an individual's risk for developing LQTS1, enabling them to implement personalized treatment plans and preventive measures. This can include lifestyle adjustments, medication, or even surgery, depending on the severity of the condition and the patient's overall health.
The test is priced at 4400 AED and is conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing services. The cost reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify and interpret genetic mutations associated with Long QT Syndrome Type 1. For individuals with a family history of LQTS or unexplained cardiac events, this test can be a critical step towards ensuring a healthier future.
The SCN4B gene plays a critical role in cardiac electrophysiology, and mutations in this gene are associated with Long QT Syndrome Type 10 (LQT10), a rare inherited heart condition. This condition can lead to irregular heartbeats, fainting, and even sudden death, especially under stress or during exercise. It's crucial for individuals with a family history of Long QT Syndrome or unexplained cardiac events to undergo genetic testing to identify potential risks.
DNA Labs UAE offers a genetic test specifically targeting the SCN4B gene to diagnose Long QT Syndrome Type 10. This test is pivotal for individuals suspecting they might carry this mutation, providing them with crucial information about their heart health and the necessary precautions to take. The test cost is 4400 AED, a valuable investment in personal health and well-being, especially for those at risk. Early detection through this test can lead to better management of the condition, including lifestyle adjustments and possibly medication to prevent life-threatening cardiac events.
The AKAP9 Gene Long QT Syndrome Type 11 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the AKAP9 gene that are associated with Long QT Syndrome Type 11 (LQT11). This condition is a rare form of Long QT Syndrome, a disorder that affects the heart's electrical activity and can lead to irregular heartbeats, fainting, and sudden death. Early detection through genetic testing is crucial for managing and treating the condition effectively.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to look for specific genetic mutations in the AKAP9 gene. These mutations can disrupt the normal function of the proteins involved in heart cell signaling, leading to the prolongation of the QT interval on an electrocardiogram (ECG).
DNA Labs UAE offers this comprehensive genetic test at a cost of 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify the genetic variations associated with LQT11. Receiving a diagnosis can be a critical step for individuals and families in managing the condition, as it can inform treatment options and lifestyle adjustments to reduce the risk of complications. Furthermore, the results can have significant implications for family members who may also carry the genetic mutation and be at risk for the syndrome.
The SNTA1 gene, associated with Long QT Syndrome Type 12 (LQT12), plays a crucial role in the electrical activity of the heart, influencing how the heart beats. Mutations in the SNTA1 gene can disrupt the heart's rhythm, leading to Long QT Syndrome, a condition characterized by prolonged heartbeats seen on an electrocardiogram. This can increase the risk of fainting, seizures, and sudden death, especially under stress or during exercise.
To identify mutations in the SNTA1 gene, a genetic test is available at DNA Labs UAE. This test is crucial for diagnosing LQT12, guiding treatment options, and determining the need for lifestyle adjustments or interventions to prevent potentially life-threatening cardiac events. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for mutations in the SNTA1 gene.
The cost of the SNTA1 Gene Long QT Syndrome Type 12 Genetic Test at DNA Labs UAE is 4400 AED. This investment in health can provide invaluable information for individuals and families affected by or at risk of LQT12, enabling proactive management and care for this serious condition.
The KCNJ5 gene is associated with Long QT Syndrome Type 13 (LQT13), a rare inherited condition that affects the heart's electrical activity and can lead to arrhythmias, fainting spells, and sudden death. The condition is characterized by prolonged repolarization of the heart after a heartbeat, which is evident in an elongated QT interval on an electrocardiogram (ECG). The KCNJ5 gene encodes for a component of potassium channels that are crucial for the proper electrical activity of the heart. Mutations in the KCNJ5 gene can disrupt the function of these channels, leading to the symptoms associated with Long QT Syndrome Type 13.
To diagnose this condition, genetic testing is available at DNA Labs UAE, a leading facility for genetic and molecular diagnostics in the United Arab Emirates. The test specifically targets the KCNJ5 gene to identify mutations that may be responsible for Long QT Syndrome Type 13. This genetic test is a crucial step in confirming the diagnosis, understanding the risk of disease progression, and guiding treatment decisions. It can also provide valuable information for family members who may be at risk.
The cost of the KCNJ5 Gene Long QT Syndrome Type 13 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis necessary to detect any mutations in the KCNJ5 gene that could indicate the presence of Long QT Syndrome Type 13. Given the potential severity of the condition, this genetic test is an important tool for individuals with a family history of the syndrome or who exhibit symptoms suggestive of a cardiac arrhythmia disorder.
The "CALM2 Gene Long QT syndrome type 15 Genetic Test" is a specialized diagnostic examination designed to identify mutations in the CALM2 gene, which are associated with Long QT Syndrome type 15 (LQT15). Long QT Syndrome is a disorder of the heart's electrical system, characterized by prolonged QT intervals on an electrocardiogram, which can lead to sudden, uncontrollable arrhythmias and, in severe cases, sudden death. Specifically, LQT15 is a subtype linked to mutations in the CALM2 gene, which plays a crucial role in calcium signaling within cardiac cells.
DNA Labs UAE offers this genetic test at a cost of 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations in the CALM2 gene. Identifying these mutations can be crucial for affected individuals and their families, as it enables personalized management strategies, including lifestyle adjustments, medications, or even surgical interventions to mitigate the risk of arrhythmias and sudden death. This test is particularly important for individuals with a family history of Long QT Syndrome or unexplained sudden cardiac deaths, as it provides essential information for early detection and intervention.
The KCNH2 Gene Long QT Syndrome Type 2 Genetic Test is a specialized diagnostic examination offered at DNA Labs UAE, designed to detect mutations in the KCNH2 gene, which are associated with Long QT Syndrome Type 2 (LQTS2). LQTS2 is a rare inherited condition characterized by abnormal heart rhythms, which can lead to fainting spells, seizures, or sudden death. The condition is named for the elongated QT interval seen on an electrocardiogram (ECG), indicative of delayed heart muscle repolarization.
This genetic test is crucial for individuals with a family history of LQTS or unexplained sudden cardiac death, as it can help in the early identification of the syndrome. Early detection is vital for the management and treatment of LQTS2, which may include lifestyle modifications, medications, or even surgical interventions to prevent potentially life-threatening arrhythmias.
The test is performed by collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific mutations in the KCNH2 gene. The process is comprehensive and designed to ensure accuracy and reliability in the results.
The cost of the KCNH2 Gene Long QT Syndrome Type 2 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of early detection and the potential to save lives through personalized treatment plans cannot be overstated. This test represents a critical step forward in the management of Long QT Syndrome and the broader field of cardiac genetics.
The SCN5A Gene Long QT Syndrome Type 3 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the SCN5A gene, which are implicated in Long QT Syndrome Type 3 (LQT3). This condition is a rare inherited disorder affecting the heart's electrical system, leading to irregular heartbeats, fainting, and at times, sudden death. The test plays a crucial role in the early detection and management of LQT3, enabling healthcare providers to implement appropriate treatments and preventive measures for individuals at risk.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic anomalies in the SCN5A gene. Positive identification of a mutation can help in guiding clinical decisions, including lifestyle adjustments, medication, or potentially implantable devices to manage heart rhythm.
Priced at 4400 AED, the SCN5A Gene Long QT Syndrome Type 3 Genetic Test is an investment in personal health, offering peace of mind and critical information for affected individuals and their families. DNA Labs UAE is equipped with state-of-the-art technology and staffed by expert geneticists and technicians, ensuring high accuracy and reliability of test results.
The ANK2 gene plays a crucial role in the regulation of cardiac electrical activity, and mutations in this gene are associated with Long QT Syndrome type 4 (LQT4), a rare inherited condition that predisposes individuals to irregular heartbeats, fainting spells, and sudden death. The ANK2 Gene Long QT Syndrome Type 4 Genetic Test is a specialized diagnostic tool used to detect mutations in the ANK2 gene, helping in the diagnosis and management of this condition.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test is essential for individuals with a family history of Long QT Syndrome or unexplained cardiac events. The test involves collecting a DNA sample, usually through a blood draw, which is then analyzed for specific genetic alterations associated with LQT4.
The cost of the ANK2 Gene Long QT Syndrome Type 4 Genetic Test is 4400 AED. While the price may seem significant, the value of the information it provides cannot be understated. Identifying a mutation in the ANK2 gene can lead to proactive management of the condition, including lifestyle adjustments, medications, or even surgical interventions to prevent potentially life-threatening cardiac events. This test is not only a crucial step in safeguarding the health of individuals with a predisposition to LQT4 but also provides invaluable peace of mind for affected families.
The KCNE1 Gene Long QT Syndrome Type 5 Genetic Test is a specialized diagnostic examination offered at DNA Labs UAE, designed to detect mutations in the KCNE1 gene, which are associated with Long QT Syndrome Type 5 (LQTS5). LQTS5 is a rare genetic disorder that affects the heart's electrical activity, leading to potentially life-threatening arrhythmias and sudden cardiac arrest. The test involves analyzing the patient's DNA to identify specific genetic alterations in the KCNE1 gene that can disrupt the normal heart rhythm.
Given the critical nature of the condition, this genetic test is an essential tool for individuals with a family history of Long QT Syndrome or unexplained cardiac events. Early detection through this test can facilitate timely intervention and management strategies to mitigate the risk of severe complications.
The cost of the KCNE1 Gene Long QT Syndrome Type 5 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to accurately identify the presence of genetic mutations associated with the condition. The test is conducted by experienced professionals in a state-of-the-art facility, ensuring reliable and precise results for patients seeking clarity about their genetic risk for Long QT Syndrome Type 5.
